NCT01644435

A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring

A Prospective, Multicentric, Open Label, Bio Interventional, Phase I, Phase II Pilot Study to Evaluate the Safety and Efficacy of Autologous Human Platelet Lysate (HPL) for Treatment of Acne Scarring

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: Kasiak Research Pvt. Ltd. · Industry
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Acne Scarring. The study is being conducted at 2 centers in India. The primary endpoint is change in the Global Acne scarring classification scores from screening to end of the study. The secondary endpoints are Photographic Assessment, Physicians assessment score and Patients self assessment score.

Conditions

• ACNE SCARRING

Interventions

Type	Name	Description
BIOLOGICAL	Autologous Human Platelet Lysate	Subjects will receive a single injection of Autologous Human Platelet Lysate for acne scarring
BIOLOGICAL	Autologous Human Platelet Lysate	Subjects will receive two injections of Autologous Human Platelet Lysate at an interval of one month for acne scarring

Timeline

• Start date: 2012-05-01
• Primary completion: 2012-10-01
• Completion: 2012-10-01
• First posted: 2012-07-19
• Last updated: 2012-10-15

Locations

1 site across 1 country: India